FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program 2018

  • 07 Mar 2018
  • Webinar

Description

FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program is a webinar that covers topics such as:

  • The Sponsor‘s responsibility in monitoring study conduct
  • What does the FDA look at when Auditing/Inspecting a study?
  • The nature of adequate oversight of all staff and non-staff
  • Components of a sponsor monitoring system beyond SOPs
  • How do sites prepare for an audit / inspection
  • The importance of Protocol knowledge in preventing errors
  • The measures to ensure quality monitoring

FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program 2018 intended for:

  • Project Managers
  • Senior Management
  • QA/Compliance Persons
  • CRA Managers
  • Clinical Research Scientists (PKs, Biostatisticians)
  • Principal Investigators and Sub Investigators
  • Clinical Research Associates (CRAs) and Cordinators (CRCs)
  • Safety Nurses
  • QA / QC Auditors and Staff
  • Recruiting Staff
  • Clinical Research Data Managers

Past Events

Important

Please, check "FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Hospitals & Clinics, Medical device, Medical laboratories, Pharma
Industry: Food & Beverages
Science: Life Sciences & Biology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions